The invention relates to compounds of the formula I A-B-Z I wherein the
variables are as defined in the claims. The compounds are pro-drugs of
A.sub.2A-receptor ligands with improved aqueous solubility, and are
useful in the treatment of neurological and psychiatric disorders where
an A.sub.2A-receptor is implicated.